Company intelligence / Profile preview

Proove Biosciences

Irvine, California, United States

Ownership: Private
Employees: ~102
Development stage: Other

Overview

Proove’s precision-medicine genetic tests have been implemented in clinical practice to assess pain sensitivity, chronic pain risk, opioid risk, therapeutic response to pain medications, and drug metabolism. The company’s research has been published in peer-reviewed journals and received awards from medical societies; the platform is in widespread clinical use, not undergoing traditional clinical trial phases.

Therapeutic areas: NeurologyPsychiatry
Modalities: Genetic testingDigital healthDiagnostics
Industry: Molecular Diagnostics

Partnerships

Licensed technology from University of North Carolina at Chapel HillLicensed technology from University of UtahLicensed technology from other academic institutions

Beyond the preview

Go deeper on Proove Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proove Biosciences.

Explore the full profile